MiddleBrook Pharmaceuticals
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Drug Delivery
- Biotechnology
Latest on MiddleBrook Pharmaceuticals
Mylan NV may be one of the world’s top generics companies, but until 2007 the company’s presence was almost entirely in the U.S. In 2012, Mylan is a global company with 2011 revenues of $6.1 billion
Shionogi's US subsidiary has agreed to acquire the entire marketed portfolio of the private US firm Victory Pharma in a move that will bolster its commercial presence in pain and infection. Shionogi I
Although the successful progress in detecting and treating HIV/AIDS over the past three decades has been "undeniable," health officials must be clear – "AIDS is not over, not around the world and not
US FDA chemist Dr Cheng Yi Liang and his 25-year-old son Andrew of Maryland were arrested 29 March on charges of insider trading based on information they gleaned from accessing government databases a